These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31007780)

  • 21. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
    Bray JJH; Warraich M; Whitfield MG; Peter CU; Baral R; Ahmad M; Ahmad S; Abraham GR; Kirresh A; Sahibzada MS; Muzaffar A; Tomson J; Lambiase PD; Captur G; Banerjee A; Providencia R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013765. PubMed ID: 36915032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of clinical outcomes following atrial fibrillation ablation for heart failure patients with preserved or reduced left ventricular function: A systematic review and meta-analysis.
    Panchal G; Kwok CS; Morley-Davies A; Zachariah D; Phan T
    Indian Pacing Electrophysiol J; 2022; 22(1):18-23. PubMed ID: 34624479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.
    Packer DL; Piccini JP; Monahan KH; Al-Khalidi HR; Silverstein AP; Noseworthy PA; Poole JE; Bahnson TD; Lee KL; Mark DB;
    Circulation; 2021 Apr; 143(14):1377-1390. PubMed ID: 33554614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients with Heart failure: A Meta-Analysis of Randomized Controlled Trials.
    Yu Z; Xing Y; Peng J; Xu B; Qi Y; Zheng Z; Qiu Y; Qiu F; Peng F
    Anatol J Cardiol; 2022 Sep; 26(9):685-695. PubMed ID: 35949135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
    Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of procedural outcomes in patients undergoing catheter vs surgical ablation for atrial fibrillation and heart failure with reduced ejection fraction.
    Doshi R; Kumar A; Shariff M; Adalja D; Patel K; Patel K; Desai R; Gullapalli N; Vallabhajosyula S
    J Arrhythm; 2021 Feb; 37(1):60-69. PubMed ID: 33664887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.
    Yamauchi R; Morishima I; Okumura K; Kanzaki Y; Morita Y; Takagi K; Nagai H; Watanabe N; Furui K; Yoshioka N; Miyazawa H; Shimojo K; Imaoka T; Sakamoto G; Murohara T
    Europace; 2021 Aug; 23(8):1252-1261. PubMed ID: 33693617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catheter ablation of atrial fibrillation in heart failure with impaired systolic function: An updated meta-analysis of randomized controlled trials.
    Chang TY; Chao TF; Lin CY; Lin YJ; Chang SL; Lo LW; Hu YF; Chung FP; Chen SA
    J Chin Med Assoc; 2023 Jan; 86(1):11-18. PubMed ID: 36227015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Androulakis E; Sohrabi C; Briasoulis A; Bakogiannis C; Saberwal B; Siasos G; Tousoulis D; Ahsan S; Papageorgiou N
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35053984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Kotecha D; Chudasama R; Lane DA; Kirchhof P; Lip GY
    Int J Cardiol; 2016 Jan; 203():660-6. PubMed ID: 26580351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials.
    Al Halabi S; Qintar M; Hussein A; Alraies MC; Jones DG; Wong T; MacDonald MR; Petrie MC; Cantillon D; Tarakji KG; Kanj M; Bhargava M; Varma N; Baranowski B; Wilkoff BL; Wazni O; Callahan T; Saliba W; Chung MK
    JACC Clin Electrophysiol; 2015 Jun; 1(3):200-209. PubMed ID: 26258174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial.
    Chieng D; Sugumar H; Segan L; Tan C; Vizi D; Nanayakkara S; Al-Kaisey A; Hawson J; Prabhu S; Voskoboinik A; Finch S; Morton JB; Lee G; Mariani J; La Gerche A; Taylor AJ; Howden E; Kistler PM; Kalman JM; Kaye DM; Ling LH
    JACC Heart Fail; 2023 Jun; 11(6):646-658. PubMed ID: 36868916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation for atrial fibrillation in HFpEF patients-A propensity-score-matched analysis.
    Rattka M; Kühberger A; Pott A; Stephan T; Weinmann K; Baumhardt M; Aktolga D; Teumer Y; Bothner C; Scharnbeck D; Rottbauer W; Dahme T
    J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2357-2367. PubMed ID: 34379370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.
    Yin J; Hu H; Wang Y; Xue M; Li X; Cheng W; Li X; Yan S
    Clin Cardiol; 2014 Nov; 37(11):707-15. PubMed ID: 25156448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-Analysis Comparing Catheter-Guided Ablation Versus Conventional Medical Therapy for Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
    Elgendy AY; Mahmoud AN; Khan MS; Sheikh MR; Mojadidi MK; Omer M; Elgendy IY; Bavry AA; Ellenbogen KA; Miles WM; McKillop M
    Am J Cardiol; 2018 Sep; 122(5):806-813. PubMed ID: 30037427
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.